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Abstract: This case report describes a case of spontaneous torsade de pointes in a dog during
pacemaker implantation that degenerated into ventricular fibrillation. We discuss the
key factors that may have precipitated this unusual complication, in which a pre-
emptive resuscitation plan contributed to a successful outcome for the patient.
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Dear Editors and Reviewers, 
 
First, thank you for your time reading and considering this case report for publication.  
Torsade de pointes is an unusual ventricular arrhythmia seen in dogs. Pacemaker 
implantation carries several risks, both related to the procedure as well as to general 
anaesthesia. Premature ventricular complexes (VPCs) is the most common reported 
arrhythmia in dogs during general anaesthesia for this procedure, likely secondary to 
mechanical stimulation of the myocardium. In our experience, these are usually a few 
self-limited VPCs that do not generally degenerate into ventricular fibrillation. 
This case report describes spontaneous torsade de pointes that degenerated into 
ventricular fibrillation in a dog. It also discusses the possible risk factors and on how 
they may have contributed for the clinical events.  
We believe that this well documented case will bring attention to another possible life 
threatening complication during pacemaker implantation and highlights the importance 
of team work and preparation on the successful outcome of this particular clinical case. 
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Torsade de pointes is an unusual complication seen in dogs during pacemaker 
implantation, although ventricular fibrillation has been previously reported. This case 
report describes torsade de pointes in a dog during pacemaker implantation that 
degenerated into ventricular fibrillation, and discusses the possible contributory 
factors. It also illustrates the relevance of a pre-emptive resuscitation plan and how 
this might have affected the outcome in the patient. 
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Torsade de pointes is an unusual complication seen in dogs during pacemaker 15 
implantation, although ventricular fibrillation has been previously reported. This case 16 
report describes torsade de pointes in a dog during pacemaker implantation that 17 
degenerated into ventricular fibrillation, and discusses the possible contributory 18 
factors. It also illustrates the relevance of a pre-emptive resuscitation plan and how 19 
this might have affected the outcome in the patient. 20 
Keywords: arrhythmia, defibrillation, anaesthesia, third degree atrioventricular block, 21 
canine. 22 
 23 
Table of abbreviations 24 
Abbreviation Definition 
AV atrioventricular 
BPM beats per minute 
ECG electrocardiogram 
IV intravenous 
PO per os 
SBP systolic blood pressure 
TdP torsade de pointes 






































































A 7.5 year old, neutered female, 33 kg Labrador retriever was presented following two 27 
weeks of exercise intolerance and three syncopal episodes. Third degree 28 
atrioventricular (AV) block had been diagnosed, and theophylline (15 mg/kg per os 29 
[PO] q 24 hr), terbutaline (0.15 mg/kg PO q 8 hr) and furosemide (1 mg/kg PO q 12 30 
hr) were started prior to referral. On auscultation, the heart rate was 40 beats per 31 
minute (bpm) with strong, matching pulses.  A grade 3/6 left apical systolic heart 32 
murmur and independent S4 heart sounds were audible. Systolic blood pressure 33 
(SBP), measured indirectly by the Doppler techniquea, was 150 mmHg.  34 
Electrocardiography confirmed third degree AV block. There were unconducted P 35 
waves, at a rate of ~140 bpm, that were positive in leads I, II, III and aVF, and 36 
maximally negative in aVR, consistent with sinus origin [1].  They appeared to march 37 
through wide ventricular escape complexes of predominantly right bundle branch block 38 
morphology (0.07 s, ~40 bpm), and, occasionally, left bundle branch block morphology 39 
(0.09 s, Fig. 1). Echocardiography identified biventricular and biatrial dilation, despite 40 
normal systolic function [2] (Table 1). During subcostal assessment, there were 41 
hepatic venous congestion and a small amount of ascites. Bradycardia-induced right-42 
sided congestive heart failure was diagnosed. Pre-anaesthetic bloodwork identified 43 
hypomagnesaemia (0.44 mmol/L, range 0.69 - 1.18 mmol/L) and moderately 44 
increased troponin-I (2.32 ng/mL, reference <0.05 ng/mL). Commercial plasma 45 
ELISAs for infectious agents (Toxoplasma gondii, Borrelia burgdoferi, Dirofilaria 46 
immitis, Erlichia canis, Erlichia ewingii, Anaplasma phagocytophilum, Anaplasma 47 
platys) associated with myocarditis were negative. Permanent pacemaker 48 




































































Prior to general anaesthesia, pimobendan (0.15 mg/kg intravenous [IV]) was 50 
administered for inotropic support. A crash plan was discussed, including team role 51 
allocation and calculation of emergency drugs doses. Premedication consisted of 52 
pethidine (5 mg/kg intramuscularly) and acepromazine (0.01 mg/kg IV). Oxygen was 53 
continuously provided by mask. The skin was clipped over the left and right precordia, 54 
and radiotransparent, low-impedance pacing padsb, with additional electrolyte gel on 55 
the contact side, were placed over the 5th-7th intercostal spaces [7].  To ensure good 56 
contact, adhesive dressing was wrapped over the pads and body wall. The electrode 57 
leads from the pads were connected to a defibrillator/monitorc. Following skin 58 
preparation, the dog was transferred to theatre and placed in left lateral recumbency 59 
for temporary transvenous pacing. A 5 French bipolar pacing leadd was inserted 60 
transcutaneously into the right lateral saphenous vein, and advanced under 61 
fluoroscopic guidance into the right ventricle. A single chamber external temporary 62 
pulse generatore was used. Temporary pacing was started (VVI, 70 bpm) and general 63 
anaesthesia induced (propofol IV to effect) followed by maintenance with isoflurane in 64 
oxygen. The temporary pacing rate was increased to 120 bpm to maintain SBP at 125 65 
mmHg. A steroid eluting, active fixation, 58 cm permanent endocardial leadf was then 66 
inserted through a right jugular venotomy, and advanced under fluoroscopic guidance 67 
towards the apex of the right ventricle, aiming for a point of insertion within the distal 68 
interventricular septum. The permanent pulse generator and lead were connected 69 
together, temporary pacing was stopped, and pacing via the permanent lead (VVI, 120 70 
bpm) was interrogated with a program system analyserg. Lead impedance was 610 . 71 
Loss of capture, using serial reductions in pacing voltage at 100 paced beats/min, 72 
occurred at 0.25 V. The sensitivity threshold, determined by serial increments in 73 




































































completion of sensitivity testing, the permanent pulse generator immediately resumed 75 
pacing at 120 bpm whereupon the patient’s rhythm deteriorated acutely into torsade 76 
de pointes (TdP) followed by ventricular fibrillation (VF) (Figure 2). Cardiopulmonary 77 
resuscitation was instigated without delay. The surgeon performed thoracic 78 
compressions at approximately 70 compressions/minute. Within 20 seconds, the 79 
anaesthetist initiated a series of three direct current shocks (6 J/kg) delivered through 80 
the transcutaneous pacing patches, separated by short periods of several seconds to 81 
assess cardiac rhythm and re-instigate thoracic compressions. After the first shock, 82 
VF was still present. After the second shock, there was a brief period of ventricular 83 
tachycardia followed by TdP that degenerated into VF (Fig. 2). After the third shock, 84 
within 60 seconds of beginning resuscitation, the rhythm returned to third degree AV 85 
block with ventricular pacing at 120 bpm. At this point, an infusion of lidocaine (3 86 
mg/kg/hr IV) was started. Blood pressure monitoring was not available after 87 
cardioversion because of electrical damage to the unit sustained during defibrillation. 88 
However, pulse quality felt subjectively strong and so pacemaker implantation was 89 
completed without further delay. Permanent lead placement was again confirmed on 90 
fluoroscopy. Lead impedance was 530  and the capture threshold test (loss of 91 
capture still at 0.25 V), but not the sensitivity test, was repeated. The lead was secured 92 
at the venotomy site and the permanent pulse generator was secured within a 93 
subcutaneous pocket. Recovery from anaesthesia was unremarkable. No further 94 
spontaneous ventricular ectopy was observed, and lidocaine was gradually withdrawn 95 
over three hours. Prophylactic antibiosis with cefuroxime (20 mg/kg IV q 2 hr) was 96 
administered intra-operatively and continued with oral potentiated amoxicillin (20 97 
mg/kg PO q 12 hr) post-operatively for 7 days.  Analgesia included buprenorphine 98 




































































methadone (0.2 mg/kg IV) due to thoracic ecchymosis at the site of the pacing pads, 100 
possibly due to mild thermal skin injury from defibrillation [8]. Following 5 days in-101 
hospital cage-rest, the patient was discharged with sotalol (1.2 mg/kg PO q 12 hr) and 102 
pimobendan (0.2 mg/kg PO q 12 hr) on restricted exercise.   103 
The patient was assessed 1 month later. Syncope had not been observed and 104 
exercise tolerance had been gradually restored.  Serum troponin-I had decreased to 105 
0.11 ng/ml. No further tests were performed due to financial restraints. The pacemaker 106 
unit was functioning appropriately with no episodes of ventricular tachycardia 107 
recorded. Sensitivity was only assessed manually by gradually increasing the 108 
programmable sensitivity and shown to be >12mV. Pimobendan and sotalol were 109 
withdrawn.  110 
 111 
DISCUSSION 112 
Torsade de pointes, or multiform ventricular flutter, is a ventricular tachycardia 113 
characterised by polymorphic QRS complexes that twist around an imaginary baseline 114 
[9, 10]. Severely restricted cardiac output and potential deterioration into VF make this 115 
arrhythmia life-threatening [11]. When VF ensues, prompt electrical defibrillation is 116 
associated with higher survival rates [12]. 117 
This case report describes the successful management of TdP degenerating into VF.  118 
Ventricular fibrillation during pacemaker implantation has been described previously 119 
in one dog [13]. We believe that preparative plans in this patient positively influenced 120 
the outcome. Pre-placement of transcutaneous pacing/defibrillating pads, and a crash 121 




































































The lead impedance and the low pacing threshold were unaffected by cardioversion, 123 
suggesting that the permanent pacing lead was not damaged. 124 
Ventricular ectopy is the most common arrhythmia during pacemaker implantation 125 
[14]. In this dog, it could have resulted from a combination of electrical and mechanical 126 
stimulation of the myocardium, which elevated troponin I suggested was inflamed. 127 
What is not clear is why ventricular ectopy should degenerate so acutely into life-128 
threatening TdP and VF in this case.   129 
Spontaneous TdP and VF are associated with prolongation of cardiac repolarisation, 130 
because, as the period of repolarisation increases, inward depolarising currents (early 131 
afterdepolarisations) and intra-myocardial electrical heterogeneity are more likely to 132 
occur [15]. Prolonged repolarisation during sinus rhythm can manifest as a long QT 133 
interval on the surface ECG. This is observed in people with inherited Long-QT1 and 134 
Long-QT2, in which dysfunctional myocardial repolarising IKs and IKr channels 135 
generate early afterdepolarisations, re-entry and TdP, thus increasing the risk of 136 
sudden death [15, 16]. 137 
Similar phenomena may occur during prolonged cardiac repolarisation in veterinary 138 
patients. For example, IKs potassium channel abnormalities have been implicated in 139 
the development of early afterdepolarisations and lethal tachyarrhythmias in German 140 
shepherd dogs [17].  The dog in this case was pacemaker dependent, and so cardiac 141 
polarisation was prolonged as a consequence of ventricular paced beats and/or 142 
endogenous escape beats that generated wide complexes on the ECG. Indeed, in 143 
experimental canine models of TdP, chronic, permanent third degree AV block is 144 
utilised to generate prolonged cardiac repolarisation from ventricular escape beats 145 




































































pharmacological or electrical stimulation. One experimental protocol includes the use 147 
of sotalol, which prolongs repolarisation further by inhibiting IKr. Therefore, the use of 148 
sotalol post-operatively in our case, which by this stage had already experienced TdP, 149 
may actually have been contra-indicated [19].  150 
Additional pharmacological influences could have come from two different 151 
sympathomimetic drugs, which were used simultaneously in this case.  Beta 2 152 
agonists, such as terbutaline, can prolong QT intervals and promote tachyarrhythmias, 153 
including VF [20, 21].  This occurs especially when combined with methylxanthines 154 
[22], such as theophylline, which inhibit phosphodiesterase III. Both agents increase 155 
intracellular calcium, promoting delayed afterdepolarisations, and triggering TdP. 156 
Such an effect has not been reported previously in dogs in a clinical setting; however, 157 
in our experience, it is unusual for a patient to receive both drugs simultaneously 158 
immediately prior to pacemaker implantation. Additional anti-phosphodiesterase III 159 
activity from pimobendan, administered before inducing anaesthesia, may also have 160 
been deleterious.   161 
Although pacemakers are routinely placed in dogs under general anaesthesia, the 162 
potential contribution of anaesthetic agents to TdP cannot be ignored. The 163 
premedicant used in this case, acepromazine, is a phenothiazine sedative that is often 164 
selected because it reduces myocardial sensitivity to catecholamines, thus reducing 165 
calcium overload.  However, it also prolongs cardiac repolarisation in dogs by inhibiting 166 
potassium channels [23]. Even the maintenance agent that was used, isoflurane, 167 
prolongs QT intervals in dogs [24, 25], promoting the development of TdP [26]. We 168 
also speculate that, pre-anaesthesia correction of the mild hypomagnesaemia could 169 
have been beneficial in this dog. Hypomagnesaemia is associated with TdP in people 170 




































































has been reported [28]. No other electrolyte abnormalities were detected in our case.  172 
Hypokalaemia reduces the ability to repolarise effectively, but, although this dog 173 
received a potassium losing diuretic, furosemide, for congestive heart failure, serum 174 
potassium levels remained within the reference range.  175 
As well as pharmacological manipulation, electrical stimulation of the heart is a likely 176 
contributory factor to the development of TdP and VF. Torsade de pointes developed 177 
immediately after the termination of permanent lead sensitivity testing, in which the 178 
program system analyser lowered the pacing rate to 30 bpm, using long cycle lengths 179 
to encourage an endogenous ventricular escape rhythm. On termination of the 180 
sensitivity test, the programmed pacing rate of 120 bpm was immediately restored. 181 
This sequence of events has similarities to the protocol for TdP induction in 182 
experimental third degree AV block in dogs [18]. In these dogs, short and long cycle 183 
lengths and prolonged pacing followed by an extrastimulus (8+1) successfully induce 184 
TdP. This pro-arrhythmic effect of pacing has also been described in people, where 185 
short-long-short pacing facilitated ventricular tachycardia/VF [29] and VF [30].  186 
Although it is not possible to determine the effect of any single agent or factor on the 187 
development of TdP and VF in this case, we believe it is reasonable to speculate on 188 
a cumulative effect of third degree AV block, myocarditis, anaesthetic agents, 189 
combination sympathomimetics, hypomagnesaemia and short-long-short cycle length 190 
pacing. This case report also illustrates the importance of preparation for defibrillation 191 
prior to pacemaker implantation, and has implications for sensitivity testing during the 192 
procedure. Most dogs with third degree AV block have wide ventricular escape 193 
complexes on ECG, suggestive of prolonged cardiac repolarisation that could increase 194 




































































a Model 811-B Doppler Ultrasonic Flow Detector, Parks Medical Inc., Aloha, Oregon, 196 
United States of America197 
b RTS (Radiotransparent) Pediatric EDGE System Electrodes with QUIK-COMBO 198 
Connector, Physio – Control  Inc., Redmond, Washington, United States of America 199 
c LIFEPAK 20e defibrillator/monitor, Physio – Control  Inc., Redmond, Washington, 200 
United States of America 201 
d Radifocus® Introducer II Standard Kit, Terumo, Leuven, Belgium 202 
e APC® External Pulse Generator type E4162, Implants Division of Devices Ltd., 203 
Hatfield, United Kingdom 204 
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Legend of figures 
 15 
Figure 1 – Electrocardiogram of the patient recorded on admission, showing 3rd degree 298 
atrioventricular block (paper speed 50 mm/s, sensitivity 5 mm/V), heart rate = 39 beats 299 
per minute, showing non-conducted P waves (A) dissociated from ventricular escape 300 
complexes of right bundle branch block morphology (B, 0.07 s duration), and left 301 
bundle branch block morphology (C, 0.09 s duration).  Coupling intervals between 302 
complexes B and C were not fixed during prolonged recording, suggesting that they 303 
arose from independent escape foci.  304 
 305 
 306 
Figure 2 – Electrocardiogram demonstrates torsade de pointes (TdP) and ventricular 307 
fibrillation (VF). This print was obtained from the defibrillator unit, and acquired before 308 
the first direct current shock. The first period of TdP prior to VF was not recorded. 309 
Ventricular fibrillation (A) is unresponsive to shock 1, converts to a polymorphic, rapid 310 
ventricular tachycardia (B) after shock 2, before degenerating into TdP (C), and then 311 




































































Table 1 – Echocardiography results of the patient on admission 
Parameter assessed Result Range [reference] 
LVIDdN (mm) 2.081 1.270 − 1.850 mm [1] 
LVIDsN (mm) 0.924 0.710 − 1.260 mm [1] 
FS (%) 52.2 25.3 – 49.9 % [2] 
EDVI (mL/m2) 104.0 32.9 − 69.1 mL/m2 [3] 
ESVI (mL/m2) 14.2 9.5 – 25.4 mL/m2 [3] 
EF (%) 86.3 54.4 – 75.7 % [3] 
LAD (mm) 31.6 25.0 – 36.0 mm [4] 
Aortic Velocity (m/s) 3.70 0.92 – 1.88 m/s [5] 
Pulmonary Velocity (m/s) 1.43 0.50 – 1.50 m/s [5] 
 
EDVI: End-diastolic volume index; EF: Ejection fraction; ESVI: End-systolic volume 
index; FS: Fractional shortening; LAD: Left atrial diameter; LVIDdN: Normalised left 
ventricular internal dimension at end-diastole; LVIDsN: Normalised left ventricular 
internal dimension at end-systole. 
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BPM beats per minute 
ECG electrocardiogram 
IV intravenous 
PO per os 
SBP systolic blood pressure 
TdP torsade de pointes 
VF ventricular fibrillation 
 
Table of abbreviations
Journal of Veterinary Cardiology 
 




The ICMJE recommends that authorship be based on the following 4 criteria: 
 
1. Substantial contributions to the conception or design of the work; or the acquisition, 
analysis, or interpretation of data for the work; AND 
2. Drafting the work or revising it critically for important intellectual content; AND 
3. Final approval of the version to be published; AND 
4. Agreement to be accountable for all aspects of the work in ensuring that questions related 
to the accuracy or integrity of any part of the work are appropriately investigated and 
resolved. 
 
Please specify the contribution of each author to the paper, e.g. study concept or design, data 
collection, data analysis or interpretation, writing the paper, others, who have contributed in other 















As Corresponding Author I hereby confirm that all listed authors in the submission meet these 
Criteria. 
 
Corresponding author: Filipe Lalanda Madruga 
 
Date: 28th April 2020 
Please add signature here: 
Geoff Culshaw – Significant contribution interpretation of data and critical analysis. Major 
contribution regarding critical revision. Final approval of the version to be published. 
 
Yolanda Martinez-Pereira – Significant critical revision.  
 
Gudrun Schoeffmann – Critical revision 
Author Agreement
